Tore Christiansen new Managing Director for Danish Diabetes Academy

Tore Christiansen new Managing Director for Danish Diabetes Academy -
06.03.18

As of 1 March 2018, Danish Diabetes Academy's Board of Directors have employed Tore Christiansen as Managing Director for Danish Diabetes Academy (DDA), who recently received a grant of 156 mio. DKK from the Novo Nordisk Foundation for another five years. He will thereby be heading a national venture with focus on education of future diabetes researchers and practitioners.

IT TAKES AN EXCEPTIONAL AND CUT-THROAT FOCUS TO MAINTAIN AND FURTHER DEVELOP THE LEAD WITHIN DIABETES RESEARCH

For many years Denmark has been in the lead when it comes to diabetes research and treatment. To maintain and further develop this leading position requires an exceptional effort and a cut-throat focus. This is exactly one of the primary tasks of DDA, who will accomplish the job through providing a wide variety of courses, symposia, networking events, allocating PhD -and Post Doc fellowships for the most talented Danish and international researchers, as well as by attracting international acknowledged researchers to Denmark through visiting professorships. 

"To solve this task, it is essential for DDA to have a strong and innovative secretariat. Therefore, the new DDA decided to hire a managing director, who possesses the right skills to build up a new secretariat, and, in addition, is able to collaborate with DDAs many stakeholders at universities, hospitals, and life-science industry of this country. Tore Christiansen is without a doubt the right candidate for the job, because he possesses these exact skills. There has been a great interest for the position with many highly qualified  applicants, but I'm happy that we managed to recruit such an experienced and competent profile", says Allan Flybjerg, Chairman for DDAs Board of Directors.

Tore Christiansen is looking very much forward to getting started with the work that lies ahead in DDA.

"Our activities within research related training and education, as well as networking collaborations, will advance the young diabetes researchers' knowledge and carreers. When all comes to all, we enable them to develop new treatments that have potential to prevent the personal and societal consequences of the debilitating disease that diabetes is", says Tore Christiansen.

CONTACT INFORMATION

Tore Christiansen, Managing Director, Danish Diabetes Academy, tel. 2964 6764
Allan Flyvbjerg, Chairman of the Board of Directors, Danish Diabetes Academy, tel. 5177 9548